LIONVILLE, Pa. (Jan. 11) — Medical components manufacturer West Pharmaceutical Services Inc. is increasing its revenue and earnings per share expectations for the fourth quarter and year-end of 2005 and reaffirming its 2006 sales target.
West expects annual sales for 2005 to be approximately $700 million, with the figure including partial-year sales of the businesses acquired during the 12-month period. The company also expects to report earnings per diluted share from continuing operations to be between 35 cents and 38 cents for the fourth quarter and between $1.35 and $1.38 for the full year.
The Lionville-based company expects full year 2006 revenues to be between $810 and $830 million, or 16- to 19-percent growth over estimated 2005 revenues, the firm said.
West will report fourth quarter and full year 2005 financial results on Feb. 21.